“This is an extremely important paper,” says Dr. Ethel Siris, a Columbia University medical professor who specializes in thinning bones and wasn’t involved in the study. “We now know that we have a therapy that has been shown to be highly effective.” “This could prevent a lot of fractures,” says Siris, who is on the board of trustees of the National Osteoporosis Foundation. “And preventing fractures in people in this age range not only prevents a lot of suffering but also saves a lot of money.”
Elizabeth Thompson, NOF, CEO, shared this: “When the experts in the field say that this study is “extremely important”, “highly effective”, “a breakthrough”, we are making progress! Reducing suffering and maintaining life quality is important for our senior population—key areas of focus for our work at NOF. As we launch our National Bone Health Policy Institute, these foundational studies that provide the data to show that treating patients early can make a difference in quality of life and savings to Medicare, remain important themes. “
To read more about this important work click here: https://www.npr.org/sections/health-shots/2018/10/01/652617693/wider-use-of-osteoporosis-drug-could-prevent-bone-fractures-in-more-elderly-wome.